CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Werte in diesem Artikel
NEW YORK, July 13, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Centene Corporation ("Centene" or "the Company") (NYSE: CNC) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Centene securities between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/CNC.
Case Details
The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Centene provided overwhelmingly positive public statements while concealing material adverse facts about its enrollment and morbidity rates; (2) the Company's internal analysis revealed that its 2025 Health Insurance Marketplace growth across 22 states—representing 72% of its marketplace membership—was significantly below expectations; (3) as a result, Centene was forced to withdraw its 2025 guidance, reducing its projected earnings to approximately $1.8 billion or an adjusted diluted EPS of $2.75; and (4) as a result of these disclosures, Centene's stock price declined dramatically, falling 40.4% from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025.
What's Next?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/CNC. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in Centene you have until September 8, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE Bronstein, Gewirtz & Grossman, LLC
Übrigens: Centene und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Centene
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Centene
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Centene Corp.
Analysen zu Centene Corp.
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.06.2015 | Centene Hold | Deutsche Bank AG | |
15.06.2015 | Centene Mkt Perform | FBR Capital | |
28.04.2015 | Centene Mkt Perform | FBR Capital | |
11.02.2015 | Centene Neutral | UBS AG | |
15.12.2014 | Centene Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
05.12.2006 | Update Centene Corp.: Sell | Goldman Sachs | |
12.06.2006 | Update Centene Corp.: Sell | Matrix Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Centene Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen